Upcoming events

2021

Handelsbanken life science innovation seminar

August

25

Add to calendar
Pareto Healthcare Conference

September

01

Add to calendar
5th Annual Digital AFDD

November

01-03

Register for the event

Add to calendar
DNB Healthcare Conference

December

16

Add to calendar

Corporate presentation, May 11 2021

CEO, Carl-Johan Dalsgaard gives an update on Vicore's operations for the virtual AGM.

Company presentation

Vicore Pharma company presentation, May 2021

Download PDF

Previous presentations

Redeye Growth Day, June 3 2021

CFO, Hans Jeppsson presented Vicore Pharma at Redeye Growth Day on June 3, 2021.

DTx webinar, May 4 2021

Presentation on the digital therapeutic (DTx) program.

KOL webinar on COVID-19, April 28 2021

Presentation by KOL Professor Maureen Horton, M.D., Johns Hopkins University School of Medicine on the current treatment landscape and unmet medical needs in treating patients with COVID-19. Update on the results from Vicore's phase II study in COVID-19 and the coming phase III pivotal study.

Redeye interview, March 30 2021

Interview with CEO Carl-Johan Dalsgaard on the results from the phase II mechanistic study in systemic sclerosis (in Swedish).

Pareto interview, March 22 2021

Interview with CEO, Carl-Johan Dalsgaard on the results from the phase II mechanistic study in systemic sclerosis and the coming phase III study in COVID-19

Webcast presentation, Dec 21 2020

Presentation of expanded results from the phase II trial in COVID-19.

Redeye interview, Dec 11 2020

Interview with Carl-Johan Dalsgaard on COVID-19 top line data.

Webcast presentation, Dec 8 2020

Presentation of top line data from the phase II trial in COVID-19.

Stora aktiedagen, Nov 10 2020

CFO, Hans Jeppsson presented Vicore Pharma at Stora Aktiedagen in Gothenburg.

Pareto Securities Healthcare Conference, Sep 5 2020

Interview with CEO, Carl-Johan Dalsgaard during Pareto Securities Healthcare Conference.

Webcast presentations, Jun 3 2020

CEO, Carl-Johan Dalsgaard presented Vicore Pharma at Avanza digitala börsdag.

Webcast presentation, Apr 28 2020

CEO, Carl-Johan Dalsgaard presented the approved upcoming phase II study with VP01 in COVID-19.

Pareto Securities, Apr 17 2020

Interview with CEO, Carl-Johan Dalsgaard (Swedish)

Webcast presentation, Mar 31 2020

CEO, Carl-Johan Dalsgaard presented the planned phase II study with C21 in COVID-19.

Sitdown interview with Finwire, Dec 16 2019

Interview with CEO, Carl-Johan Dalsgaard (swedish only)

Avanza börsdag, Nov 19 2019

Company presentation with CEO, Carl-Johan Dalsgaard

Pareto Health Care Conference, Sep 5 2019

Interview with CEO, Carl-Johan Dalsgaard